Jpmorgan Chase & CO Cv Rx, Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Cv Rx, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 5,914 shares of CVRX stock, worth $51,037. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,914
Previous 29,158
79.72%
Holding current value
$51,037
Previous $530,000
86.79%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CVRX
# of Institutions
75Shares Held
13.5MCall Options Held
49.9KPut Options Held
2.1K-
Johnson & Johnson New Brunswick, NJ4.1MShares$35.4 Million16.99% of portfolio
-
Nea Management Company, LLC Timonium, MD2.37MShares$20.5 Million2.68% of portfolio
-
Black Rock Inc. New York, NY876KShares$7.56 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA664KShares$5.73 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT587KShares$5.07 Million0.71% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $178M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...